Alice Nettleton
Equity research analyst · UBS
Earnings calls
1
Nov 12, 2026 – Nov 12, 2026
Stocks asked about
1
Questions
1
Firm rating actions
0
on these stocks, from news
Coverage
Companies whose earnings calls Alice Nettleton asked questions on (from Lician's transcripts).
Questions on earnings calls
- NKTR earnings call · NEKTAR THERAPEUTICSNov 12, 2026 · 1 question
- 1:08:30
“You seem to have benefited from the setbacks with OX40+, which makes sense. There are several atopic derm competitor readouts coming up, including STAT-6 and various bispecifics and trispecifics. If any of these were to have that's not allowed up, they would do it to theЗe as…”
- 1:08:30
Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.
UBS rating actions on these stocks
From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Alice Nettleton. We do not use licensed rating databases.
No rating action by UBS on these stocks in the headlines we store yet.